Michael L. Cher

Michael L. Cher

Urology
5250 Auto Club Drive
Suite 290A
Dearborn, MI 48126

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: August 24, 2026

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: August 20, 2026

Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.

Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.

Journal: The Journal of urology
Published: July 06, 2026

Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy.

Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy.

Journal: BJU international
Published: May 07, 2026

Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete.

Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance Athlete.

Journal: Cureus
Published: April 14, 2026

Real-World Experience With Prostate-Specific Membrane Antigen-Positron Emission Tomography in Primary Staging and Biochemical Recurrence Settings: Data From the Michigan Urological Surgery Improvement Collaborative.

Real-World Experience With Prostate-Specific Membrane Antigen-Positron Emission Tomography in Primary Staging and Biochemical Recurrence Settings: Data From the Michigan Urological Surgery Improvement Collaborative.

Journal: Urology practice
Published: March 12, 2026

Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.

Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trial.

Journal: JNCI cancer spectrum
Published: January 17, 2026

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: October 24, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: October 15, 2025

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.

Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.

Journal: The Journal of urology
Published: September 16, 2025

How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic Test.

How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic Test.

Journal: JCO oncology practice
Published: September 11, 2025

Tumor Rupture During Partial Nephrectomy: More Questions than Answers.

Tumor Rupture During Partial Nephrectomy: More Questions than Answers.

Journal: European urology open science
Published: March 07, 2025
Showing 1-12 of 85

Last Updated: 09/26/2026